Ranbaxy and Orchid Chemicals & Pharmaceuticals have entered into a business alliance agreement involving multiple geographies and therapies for both finished dosage formulations and active pharmaceutical ingredients (API). Additionally, this agreement would establish a synergestic association between the two companies.